TCI GENE Inc. (6879.TWO)
TWD 56.0
(0.0%)
TWD 56.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 17.84 Million | 110.35 Million | 119.18 Million | 54.63 Million | - |
| Net Income | 8.77 Million | 90.13 Million | 116.43 Million | 47.96 Million | - |
| Depreciation & Amortization | 15.93 Million | 29.64 Million | 37.83 Million | 7.44 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | 7.26 Million | - | - |
| Change in working capital | -10.87 Million | 3.86 Million | -34.46 Million | 2.04 Million | - |
| Other non-cash items | -8.55 Million | -2.21 Million | 733 Thousand | -69 Thousand | - |
| Investing Cash Flow | -203.86 Million | -39.99 Million | -26.95 Million | -28.92 Million | - |
| Investments in PPE | -3.16 Million | -15.29 Million | -23.42 Million | -22.91 Million | - |
| Acquisitions | - | -24 Million | - | - | - |
| Investment purchases | -198.6 Million | -1 Million | -5.23 Million | -500 Thousand | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -2.09 Million | -492 Thousand | 811 Thousand | -5.51 Million | - |
| Financing Cash Flow | -50.64 Million | 535.72 Million | 54.61 Million | - | - |
| Debt repayment | -6.7 Million | -8.72 Million | -5.32 Million | - | -12 Million |
| Dividends payments | -52.91 Million | -53.64 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | 577.5 Million | 59.94 Million | - | - |
| Other Financing Activities | 8.98 Million | 20.59 Million | 59.94 Million | - | - |
| Accounts receivables | -31.04 Million | 44.72 Million | -72.47 Million | -11.76 Million | - |
| Accounts payables | 15.45 Million | - | - | - | - |
| Inventory | 2.18 Million | -25.79 Million | -1.19 Million | -21.71 Million | - |
| Other working capital | 2.86 Million | 1.84 Million | 21.86 Million | -931 Thousand | - |
| Cash at beginning of period | 932.73 Million | 326.18 Million | 177.56 Million | 151.75 Million | - |
| Cash at end of period | 696.04 Million | 932.73 Million | 326.18 Million | 177.56 Million | - |
| Capital Expenditure | -3.16 Million | -15.29 Million | -23.42 Million | -22.91 Million | - |
| Effect of forex changes on cash | -35 Thousand | 468 Thousand | 1.77 Million | 105 Thousand | - |
| Net cash flow / Change in cash | -236.69 Million | 606.55 Million | 148.62 Million | 25.81 Million | - |
| Free Cash Flow | 14.68 Million | 95.06 Million | 95.76 Million | 31.72 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 11.8 Million | 11.8 Million | 1.89 Million | 8.77 Million | 1.89 Million | 3.94 Million |
| Depreciation & Amortization | 3.61 Million | 3.61 Million | 3.57 Million | 15.93 Million | 3.57 Million | 3.94 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 12.32 Million | 12.32 Million | -14.1 Million | -10.87 Million | -14.1 Million | 1.1 Million |
| Other non-cash items | -16.24 Million | -16.24 Million | -4.75 Million | -8.55 Million | -4.75 Million | 13.32 Million |
| Investing Cash Flow | -236.64 Million | -236.64 Million | -25.43 Million | -203.86 Million | -25.43 Million | -76.49 Million |
| Investments in PPE | -67.5 Thousand | -67.5 Thousand | -294 Thousand | -3.16 Million | -294 Thousand | -899 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -633.63 Million | - | - | -198.6 Million | - | - |
| Sales/Maturities of investments | 158.6 Million | - | - | - | - | - |
| Other Investing Activities | -236.57 Million | -236.57 Million | -25.13 Million | -2.09 Million | -25.13 Million | -75.6 Million |
| Financing Cash Flow | -1.67 Million | -1.67 Million | -24.75 Million | -50.64 Million | -24.75 Million | -567.5 Thousand |
| Debt repayment | -765 Thousand | - | - | -6.7 Million | - | - |
| Dividends payments | - | - | -26.45 Million | -52.91 Million | -26.45 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.67 Million | -1.67 Million | 1.7 Million | 8.98 Million | 1.7 Million | -567.5 Thousand |
| Accounts receivables | 14.61 Million | 14.61 Million | -18.52 Million | -31.04 Million | -18.52 Million | 2.99 Million |
| Accounts payables | -16.26 Million | - | - | - | - | - |
| Inventory | -801 Thousand | -801 Thousand | 608 Thousand | 2.18 Million | 608 Thousand | 483 Thousand |
| Other working capital | -1.48 Million | -1.48 Million | 3.8 Million | 2.86 Million | 3.8 Million | -2.37 Million |
| Cash at beginning of period | 696.04 Million | - | - | 932.73 Million | - | - |
| Cash at end of period | -226.71 Million | -226.71 Million | -63.94 Million | 696.04 Million | -63.94 Million | -54.4 Million |
| Capital Expenditure | -67.5 Thousand | -67.5 Thousand | -294 Thousand | -3.16 Million | -294 Thousand | -899 Thousand |
| Effect of forex changes on cash | 110 Thousand | 110 Thousand | -365 Thousand | -35 Thousand | -365 Thousand | 347.5 Thousand |
| Net cash flow / Change in cash | -922.75 Million | -226.71 Million | -63.94 Million | -236.69 Million | -63.94 Million | -54.4 Million |
| Free Cash Flow | 11.42 Million | 11.42 Million | -13.68 Million | 14.68 Million | -13.68 Million | 21.41 Million |
0A60
QATI
AGF-B
7575
S
603329